Clinical Trial Detail

NCT ID NCT04057365
Title A Single Arm Phase II Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

intrahepatic cholangiocarcinoma

gallbladder cancer

cholangiocarcinoma

Therapies

DKN-01 + Nivolumab

Age Groups: adult senior

No variant requirements are available.